Literature DB >> 26692115

Idiopathic pulmonary hemosiderosis in adults: review of cases reported in the latest 15 years.

Xi-Yuan Chen1, Jin-Ming Sun2, Xiao-Jun Huang1.   

Abstract

BACKGROUND: Idiopathic pulmonary hemosiderosis (IPH) is a rare disorder of unknown etiology which can cause diffuse alveolar hemorrhage. IPH is found primarily in children. In adults, however, it is extremely rare. A systematic review was applied to identify the details of IPH in adults.
METHODS: Articles of English or Chinese language published between 2000 and 2015 were included. Data were extracted on the clinical features, examinations, treatments and clinical outcome.
RESULTS: A total of 37 cases of adult-onset IPH were included (13 females and 24 males). IPH combined with coeliac disease was found in five patients, three of whom received gluten-free diet (GFD) only and got full remission. Upon diagnosis, median age was 34 years. The main manifestations were: hemoptysis (n = 30, 81%), dyspnea (n = 23, 64%), anemia (n = 20, 54%). Most patients were treated by corticosteroids initially. The mortality rage was 14% on acute phase.
CONCLUSION: The adult patients in this study showed some differences from the previously characterized IPH. It is characterized by immunologically mediated, middle-age onset, male dominance, absence of anemia, high mortality on acute phase.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Idiopathic pulmonary hemosiderosis; adult-onset; autoimmune; diffuse alveolar hemorrhage

Mesh:

Substances:

Year:  2016        PMID: 26692115     DOI: 10.1111/crj.12440

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   1.761


  12 in total

Review 1.  Differentiation of idiopathic pulmonary hemosiderosis from rheumatologic and autoimmune diseases causing diffuse alveolar hemorrhage: establishing a diagnostic approach.

Authors:  Biplab K Saha; Woon H Chong; Nils T Milman
Journal:  Clin Rheumatol       Date:  2021-09-07       Impact factor: 3.650

Review 2.  Adult patients with idiopathic pulmonary hemosiderosis: a comprehensive review of the literature.

Authors:  Biplab K Saha; Alyssa Bonnier; Santu Saha; Baidya Nath Saha; Boris Shkolnik
Journal:  Clin Rheumatol       Date:  2022-02-18       Impact factor: 3.650

Review 3.  Proposed Pathogenesis of Diffuse Alveolar Hemorrhage in Idiopathic Pulmonary Hemosiderosis.

Authors:  Biplab K Saha; Woon H Chong; Santu Saha; Alexis Aiman; Alyssa Bonnier
Journal:  Lung       Date:  2022-03-10       Impact factor: 3.777

4.  Perls' Prussian Blue Stains of Lung Tissue, Bronchoalveolar Lavage, and Sputum.

Authors:  Andrew J Ghio; Victor L Roggli
Journal:  J Environ Pathol Toxicol Oncol       Date:  2021       Impact factor: 3.567

Review 5.  Comparative Analysis of Adult Patients With Idiopathic Pulmonary Hemosiderosis and Lane-Hamilton Syndrome: A Systematic Review of the Literature in the Period 1971-2022.

Authors:  Biplab K Saha; Praveen Datar; Alexis Aiman; Alyssa Bonnier; Santu Saha; Nils T Milman
Journal:  Cureus       Date:  2022-03-25

Review 6.  Idiopathic pulmonary hemosiderosis: a review of the treatments used during the past 30 years and future directions.

Authors:  Biplab K Saha; Nils T Milman
Journal:  Clin Rheumatol       Date:  2020-11-12       Impact factor: 3.650

Review 7.  Prevalence of autoantibodies in pediatric patients with idiopathic pulmonary hemosiderosis: a scoping review of the literature in the period 1980-2021.

Authors:  Biplab K Saha; Alyssa Bonnier; Praveen Chenna; Nils T Milman
Journal:  Clin Rheumatol       Date:  2022-01-24       Impact factor: 3.650

8.  Diffuse alveolar haemorrhage with suspected idiopathic pulmonary hemosiderosis and decrease in lung diffusing capacity and chronic respiratory failure.

Authors:  Kotaro Iwasaki; Yasuo Matsuzawa; Hiroki Wakabayashi; Kotaro Kumano
Journal:  BMJ Case Rep       Date:  2021-07-02

9.  Clinical characteristics and prognosis of idiopathic pulmonary hemosiderosis in pediatric patients.

Authors:  Yajun Zhang; Fenglan Luo; Nini Wang; Yue Song; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-10-02       Impact factor: 1.573

10.  Can a gluten-free diet be partly protective for COVID-19 infection?

Authors:  Martin Haupt-Jorgensen; Karsten Buschard
Journal:  APMIS       Date:  2020-10       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.